Documentos de Iznaga N. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Palabras Claves: "Monoclonal antibody"

Subtipo de publicación

Publisher

Cancer Biology and Therapy(1)

Cancer Biotherapy and Radiopharmaceuticals(1)

Journal of Immunotherapy(1)

Área temáticas

Enfermedades(3)

Farmacología y terapéutica(3)

Área de conocimiento

Farmacología(1)

Inmunología(1)

Objetivos de Desarrollo Sostenible

ODS 10: Reducción de las desigualdades(3)

ODS 17: Alianzas para lograr los objetivos(3)

ODS 3: Salud y bienestar(3)

Año de Publicación

Origen

Palabras Claves

Epidermal growth factor receptor(3)

Phase I clinical trial(2)

immunotherapy(2)

Squamous cell carcinoma of the head and neck(1)

Targeted therapy(1)

Pharmacological Evaluation of Humanized Anti-Epidermal Growth Factor Receptor, Monoclonal Antibody h-R3, in Patients With Advanced Epithelial-Derived Cancer

Abstract: Epidermal growth factor receptor (EGFR) overexpression has been detected in many tumors of epithelia

Palabras claves:

Epidermal growth factor receptor, Monoclonal antibody, Phase I clinical trial

Catala M., Iznaga N., Lage Davila A., Neninger Vinageras E., Perera A., Pérez R., Solano M., Tania Crombet, Torres F., Torres L., Torres O.

Phase I clinical evaluation of a neutralizing monoclonal antibody against Epidermal Growth Factor Receptor

Abstract: Ior egf/r3 a neutralizing monoclonal antibody (mAb) against Epidermal Growth Factor Receptor (EGFR)

Palabras claves:

Epidermal growth factor receptor, immunotherapy, Monoclonal antibody, Phase I clinical trial, Tyrosine kinase inhibitors

Catalaá M., Fernández E., Iznaga N., Neninger Vinageras E., Peérez R., Ramos M., Rodríguez N., Tania Crombet, Torres O.

Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck

Abstract: The prognosis of patients with advanced head and neck cancer remain dismal. For this tumor type, ele

Palabras claves:

Epidermal growth factor receptor, immunotherapy, Monoclonal antibody, nimotuzumab, Squamous cell carcinoma of the head and neck, Targeted therapy

Alert J., Bahi R.D.C., Bárbara Wilkinson, Bilbao M.A., Carmen Elena Viada, De Armas E.L., Frómeta M., Galainena J.J., Gracias E., Iznaga N., Leonard I., Luaces P.L.o., Muchuli C.R., Mulén B., Mullens V., Pérez K., Pineda I., Rivero T.C., Rodríguez E., Rodríguez M.O., Tania Crombet, Torres O., Vinageras E.N.